Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

Abstract Background Myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) are related to several acquired demyelinating syndromes in adults, but the therapeutic approach is currently unclear. We aimed to describe the response to different therapeutic strategies in adult patients with relapsing MOG...

Full description

Bibliographic Details
Main Authors: Alvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, Thais Armangué, Anne Ruiz, Elisabeth Maillart, Caroline Papeix, Bertrand Audoin, Helene Zephir, Damien Biotti, Jonathan Ciron, Francoise Durand-Dubief, Nicolas Collongues, Xavier Ayrignac, Pierre Labauge, Eric Thouvenot, Bertrand Bourre, Alexis Montcuquet, Mikael Cohen, Romain Deschamps, Nuria Solà-Valls, Sara Llufriu, Jerome De Seze, Yolanda Blanco, Sandra Vukusic, Albert Saiz, Romain Marignier
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Journal of Neuroinflammation
Subjects:
MOG antibodies
Treatment response
Neuromyelitis optica
Multiple sclerosis
Propensity score
Online Access:http://link.springer.com/article/10.1186/s12974-019-1525-1

Internet

http://link.springer.com/article/10.1186/s12974-019-1525-1

Similar Items